Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
American Heart Journal
|
March 31, 2000
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee
D J Moliterno
The Journal of Emergency Medicine
|
October 26, 2000
Combination therapy: management of acute myocardial infarction in the new millennium
D J Moliterno
The American Journal of Cardiology
|
May 4, 2000
Achieving tissue-level perfusion in the setting of acute myocardial infarction
D Mukherjee, D J Moliterno
American Heart Journal
|
December 2, 2000
Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine
D J Moliterno, D Mukherjee
Clinical Pharmacokinetics
|
February 24, 2001
Monitoring antiplatelet therapy: What is the best method?
D Mukherjee, D J Moliterno
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Applications of anti-platelet monitoring in catheterization laboratory
D Mukherjee, D J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 22, 2001
Thrombolytic therapy for acute myocardial infarction
J M Estess, D J Moliterno
The Journal of Emergency Medicine
|
May 25, 1999
Treatment of non-ST-segment-elevation acute coronary syndromes with platelet glycoprotein IIb/IIIa inhibitors: an emergency department perspective
M T Roe, D J Moliterno
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Platelet glycoprotein IIb/IIIa receptor antagonists
I P Casserly, D J Moliterno
Journal of the American College of Cardiology
|
December 29, 2000
A critical appraisal of platelet glycoprotein IIb/IIIa inhibition
D P Chew, D J Moliterno
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
American Heart Journal
|
March 31, 2000
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee
D J Moliterno
The Journal of Emergency Medicine
|
October 26, 2000
Combination therapy: management of acute myocardial infarction in the new millennium
D J Moliterno
The American Journal of Cardiology
|
May 4, 2000
Achieving tissue-level perfusion in the setting of acute myocardial infarction
D Mukherjee, D J Moliterno
American Heart Journal
|
December 2, 2000
Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine
D J Moliterno, D Mukherjee
Clinical Pharmacokinetics
|
February 24, 2001
Monitoring antiplatelet therapy: What is the best method?
D Mukherjee, D J Moliterno
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Applications of anti-platelet monitoring in catheterization laboratory
D Mukherjee, D J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 22, 2001
Thrombolytic therapy for acute myocardial infarction
J M Estess, D J Moliterno
The Journal of Emergency Medicine
|
May 25, 1999
Treatment of non-ST-segment-elevation acute coronary syndromes with platelet glycoprotein IIb/IIIa inhibitors: an emergency department perspective
M T Roe, D J Moliterno
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Platelet glycoprotein IIb/IIIa receptor antagonists
I P Casserly, D J Moliterno
Journal of the American College of Cardiology
|
December 29, 2000
A critical appraisal of platelet glycoprotein IIb/IIIa inhibition
D P Chew, D J Moliterno
Page
of 9